In another study by Marvalim and colleagues [27], they reviewed the role of p53 in breast cancer progression, emphasising its regulatory functions in response to genotoxic stress and its frequent inactivation through mutation or MDM2 overexpression. This evidence concerns the gene MDM2 and breast cancer.